InsiderClue
Insiders · Profile

Mahadevia Ankit

Director at Spero Therapeutics. Filing since 5 Jul 2018. CIK 0001720974

Company
Date
Role
Action
Shares
Amount
Of holding
SPRO Spero Therapeutics, Inc.
28 Aug 2025
Director
Sold at will
6,572
$12.95K
0.9%
SPRO Spero Therapeutics, Inc.
5 Feb 2025
Director
Sold at will
69,219
$53.99K
9.1%
SPRO Spero Therapeutics, Inc.
27 Aug 2024
Director
Sold at will
5,912
$7.98K
0.8%
SPRO Spero Therapeutics, Inc.
2 Feb 2024
Director
Sold at will
63,795
$87.40K
7.9%
SPRO Spero Therapeutics, Inc.
28 Aug 2023
Director
Sold at will
9,040
$11.39K
1.1%
SPRO Spero Therapeutics, Inc.
3 Feb 2023
CEO and President
Sold, plan not stated
12,286
$22.24K
1.5%
SPRO Spero Therapeutics, Inc.
27 Dec 2021
CEO and President
Sold, plan not stated
8,000
$116.67K
5.3%
SPRO Spero Therapeutics, Inc.
4 Nov 2020
CEO and President
Sold, plan not stated
7,370
$106.34K
10.1%
SPRO Spero Therapeutics, Inc.
3 Nov 2020
CEO and President
Sold, plan not stated
2,137
$30.49K
3.1%
SPRO Spero Therapeutics, Inc.
23 Oct 2020
CEO and President
Sold, plan not stated
20
$285.00
0.0%
SPRO Spero Therapeutics, Inc.
14 Oct 2020
CEO and President
Sold, plan not stated
105
$1.50K
0.2%
SPRO Spero Therapeutics, Inc.
13 Oct 2020
CEO and President
Sold, plan not stated
14,367
$205.21K
17.9%
SPRO Spero Therapeutics, Inc.
8 Sep 2020
CEO and President
Sold, plan not stated
774
$11.03K
1.2%
SPRO Spero Therapeutics, Inc.
9 Jul 2020
CEO and President
Sold, plan not stated
2,293
$32.81K
3.4%
SPRO Spero Therapeutics, Inc.
7 Jul 2020
CEO and President
Sold, plan not stated
754
$10.74K
1.1%
SPRO Spero Therapeutics, Inc.
25 Jun 2020
CEO and President
Sold, plan not stated
2,642
$37.65K
3.9%
SPRO Spero Therapeutics, Inc.
24 Jun 2020
CEO and President
Sold, plan not stated
3,880
$55.42K
5.6%
SPRO Spero Therapeutics, Inc.
23 Jun 2020
CEO and President
Sold, plan not stated
8,045
$115.26K
10.9%
SPRO Spero Therapeutics, Inc.
22 Jun 2020
CEO and President
Sold, plan not stated
2,613
$37.36K
3.8%
SPRO Spero Therapeutics, Inc.
6 Jul 2018
See Remarks
Sold, plan not stated
1,600
$28.23K
2.4%
SPRO Spero Therapeutics, Inc.
5 Jul 2018
See Remarks
Sold, plan not stated
3,076
$54.20K
4.5%
21 decisions on file.